Changes in surface expression of N-methyl-D-aspartate receptors in the striatum in a rat model of Parkinson's disease. - Wikidata - awgldk - TriplyDB

Changes in surface expression of N-methyl-D-aspartate receptors in the striatum in a rat model of Parkinson's disease.

Changes in surface expression of N-methyl-D-aspartate receptors in the striatum in a rat model of Parkinson's disease.

http://www.wikidata.org/entity/Q37509323

about

p120-catenin is necessary for neuroprotection induced by CDK5 silencing in models of Alzheimer's disease Roles of Ca(2+)/calmodulin-dependent protein kinase II in subcellular expression of striatal N-methyl-D-aspartate receptors in l-3, 4-dihydroxyphenylalanine-induced dyskinetic rats.

P2860

Q28386238-58B5D924-59E4-4148-BF0E-ED65979B7556 Q35492255-945A43D7-668B-443E-A098-B275F5AE3DD5

P2860

Changes in surface expression of N-methyl-D-aspartate receptors in the striatum in a rat model of Parkinson's disease.

http://www.wikidata.org/entity/Q37509323

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Changes in surface expression ...... model of Parkinson's disease.

@en

Changes in surface expression ...... model of Parkinson's disease.

@nl

type

label

Changes in surface expression ...... model of Parkinson's disease.

@en

Changes in surface expression ...... model of Parkinson's disease.

@nl

prefLabel

Changes in surface expression ...... model of Parkinson's disease.

@en

Changes in surface expression ...... model of Parkinson's disease.

@nl

P1433

Q37509323-D164D87B-0F38-4CBA-9B8B-EA5A5759A140

P1476

Q37509323-76C08196-43EF-4A7B-BBCD-FFCD667B1101

P2093

Q37509323-3825AB56-9791-45A9-83CE-582A3104E9DF

Q37509323-3D048BA7-6F9A-440A-8C89-75BBB1CAA391

Q37509323-536CEFFA-4108-4FB4-BA18-D560072D7C0F

Q37509323-AF076257-D044-448D-8998-20DA06E6AE26

P2860

Q37509323-0327EBD3-98F5-4EAE-826E-15905B62349C

Q37509323-03E3F070-EFEF-4C38-8AAA-9C837DDE017D

Q37509323-148C7C2D-4412-4235-B651-39D11F04C52F

Q37509323-1BE0CA35-0ED7-4EBE-B1AD-43A7F38BF2FB

Q37509323-2F9D348E-A302-4947-ABF0-09FDDDD6F25E

Q37509323-30A1B211-8A5A-422E-B743-FECD398D86A1

Q37509323-38D67271-C031-4207-BBAA-B14B47727D22

Q37509323-5AECB399-3175-4676-B9E3-80322400D47E

Q37509323-65FDAF11-06C7-4A4A-8DF1-089FF7FF0045

Q37509323-71B385BB-6A8E-4A75-92D9-14971A4CAC39

P304

Q37509323-E4DA36CF-267B-4A50-808B-F669D977C7A0

P31

Q37509323-EEAB5450-C6D1-4937-971F-C0D97F8F7F0F

P356

Q37509323-6D03034D-8A95-4F93-BF38-0F2EB919684F

P407

Q37509323-FC4C5967-CEA6-41E2-8D77-7A217BB5A00D

P478

Q37509323-649A7A6D-7F7C-42E2-91BA-36F9F5838D37

P577

Q37509323-830FDBD7-5BB7-485D-A3B6-834A0E6E4941

P698

Q37509323-50617723-99CE-4F58-9CCE-1D960786B07A

P921

Q37509323-A5151EAF-C9DC-4151-9990-2FB99AB39FD3

Q37509323-B9154C07-8390-4341-A1A7-007E83353EDC

P932

Q37509323-D64A8FCF-D3C9-42EC-8777-345441BF79DF

P356

P1433

Drug Design, Development and Therapy

P1476

Changes in surface expression ...... model of Parkinson's disease.

@en

P2093

Chen Qi

http://www.w3.org/2001/XMLSchema#string

Jing Gan

http://www.w3.org/2001/XMLSchema#string

Li-Min Mao

http://www.w3.org/2001/XMLSchema#string

Zhenguo Liu

http://www.w3.org/2001/XMLSchema#string

P2860

The glutamate receptor ion channels

Glutamate receptor ion channels: structure, regulation, and function

A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia

Stability of surface NMDA receptors controls synaptic and behavioral adaptations to amphetamine.

Enhanced glutamate, IP3 and cAMP activity in the cerebral cortex of unilateral 6-hydroxydopamine induced Parkinson's rats: effect of 5-HT, GABA and bone marrow cell supplementation.

The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications.

Dynamic loss of surface-expressed AMPA receptors in mouse cortical and striatal neurons during anesthesia.

Ionotropic and metabotropic glutamate receptor structure and pharmacology.

The 6-hydroxydopamine model of Parkinson's disease.

The 6-hydroxydopamine model: news from the past.

P304

165-173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S51559

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24465126

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

corpus striatum

P932

3900317

http://www.w3.org/2001/XMLSchema#string